恒為科技(603496.SH):推出的昇騰Deepseek一體機分為訓推一體機與推理一體機兩種類型
格隆匯4月11日丨恒為科技(603496.SH)在投資者互動平台表示,公司推出的昇騰Deepseek一體機分為訓推一體機與推理一體機兩種類型,以“開箱即用+高併發低時延”為核心優勢,覆蓋金融、政務、科研、醫療等眾多垂直行業,助力行業實現智能化升級。該系列產品結合了Deepseek大模型的“高性價比+低資源消耗”特性與華為昇騰平台的國產自主AI芯片架構,通過軟硬協同創新,構建了從訓練到推理的全棧能力。訓推一體機支持完整的AI模型訓練和推理功能,而推理一體機則專注於高效能推理場景,兩者形成完整的AI算力基礎設施矩陣,為千行萬業智能化轉型提供安全可靠的創新底座。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.